CIDRAP newsletters options
"This is a time for optimism, but not a time for relaxation," Biden says.
People commonly experience fatigue, cognitive conditions, or shortness of breath, says a new study.
The estimated protection against reinfection was about 80%, but for seniors it was only 47%.
Both the EMA and the UK's drug regulatory agency weigh in and say the data vouch for effectiveness and safety.
An audit of an electronic medical record–integrated antimicrobial stewardship intervention in an Australian intensive care unit (ICU) demonstrated long-term benefits and sustainability, Australian researchers reported today in Infection Control & Hospital Epidemiology.
COVID-19 vaccination coverage in less socioeconomically vulnerable US counties was 1.9 percentage points higher than that in the most susceptible counties in the first 2.5 months of vaccine rollout, a study yesterday in Morbidity and Mortality Weekly Report (MMWR) finds.
Brazil's activity intensified after Carnival, and, unlike its first surge, spikes aren't contained to a few main hot spots.
Researchers who tracked B117 variant spread in the UK found that the virus quickly found its way into nursing homes.
Hot spots include the Upper Midwest, Northeast, and Middle Atlantic and may reflect variant spread.
Among 3,008 US nursing homes in counties in the top quartile of COVID-19 prevalence, those with larger proportions of racial minority residents, Medicaid participants, and fewer direct patient care hours experienced more coronavirus infections amid the pandemic, according to a research letter published yesterday in JAMA Network Open.
A team of Indian scientists yesterday reported the detection of Candida auris isolates from two sampling sites on islands in the Indian Ocean—the first time the multidrug-resistant yeast has been isolated in a natural environment. The discovery was reported in mBio.
The trial wasn't able to assess impact against severe disease because of the relatively young age of participants.
About 12% of the US population is fully vaccinated, and at least 21% have 1 dose.
The European Medicines Agency and an expert WHO group are reviewing vaccine data.
Melinta Therapeutics of Morristown, New Jersey, announced yesterday that the US Food and Drug Administration (FDA) has approved Kimyrsa (oritavancin) for treatment of adult patients with acute bacterial skin and skin-structure infections (ABSSSIs) caused by susceptible gram-positive pathogens, including methicillin-resistant Staphylococcus aureus (MRSA).
Roughly 15.9 million asymptomatic US COVID-19 cases may have gone undetected as of Sep 30, 2020, which would double the cases reported to the Centers for Disease Control and Prevention (CDC) during that time, according to a research letter detailing a 6.6% nationwide SARS-CoV-2 seroprevalence rate.
In other hopeful news, 1 dose of the Pfizer vaccine may be 63% effective.
The proportion of antibiotics obtained without a prescription is highest in Vietnam and Bangladesh.
Findings in more than 2.2 million people suggest B117 has a 61% higher death rate.
Probes by European regulators and AstraZeneca have found no link between the vaccine and blood clotting or bleeding.
